Definitive Healthcare Corp

For the period ended Mar 31, 2024. Filed May 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 7, 2024

DH$1.19+6.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share amounts and per share data)

	Three Months Ended March 31,
	2024	2023
Revenue	$63,480	$59,201
Cost of revenue:
Cost of revenue exclusive of amortization	9,736	8,552
Amortization	3,362	3,354
Gross profit	50,382	47,295
Operating expenses:
Sales and marketing	21,760	23,423
Product development	10,132	9,884
General and administrative	16,883	14,079
Depreciation and amortization	9,322	9,590
Transaction, integration, and restructuring expenses	8,534	2,590
Total operating expenses	66,631	59,566
Loss from operations	(16,249)	(12,271)
Other income (expense), net:
Interest income	3,927	2,834
Interest expense	(3,816)	(3,614)
Gain (loss) on remeasurement of tax receivable agreement liability	2,267	(3,552)
Other income (expense), net	373	(79)
Total other income (expense), net	2,751	(4,411)
Net loss before income taxes	(13,498)	(16,682)
Benefit from income taxes	780	710
Net loss	(12,718)	(15,972)
Less: Net loss attributable to noncontrolling interests	(3,200)	(3,909)
Net loss attributable to Definitive Healthcare Corp.	$(9,518)	$(12,063)
Net loss per share of Class A Common Stock:
Basic and diluted	$(0.08)	$(0.11)
Weighted average Class A Common Stock outstanding:
Basic and diluted	117,433,520	108,234,043

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.